Search / 65 results found


WEDNESDAY, Jan. 19, 2022 (HealthDay News) -- The U.S. Food and Drug Administration approved Rinvoq (upadacitinib) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older, the manufacturer announced Friday.

WEDNESDAY, Jan. 19, 2022 (HealthDay News) -- There are racial and ethnic disparities in receipt of monoclonal antibody (mAb) treatment among patients with COVID-19, according to research published in the Jan. 14 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

WEDNESDAY, Jan. 19, 2022 (HealthDay News) -- No magic bullet exists for ending the U.S. opioid crisis, but there's hopeful news for one high-risk population: Providing addiction medication in jails reduces the odds of addicts being re-arrested after their release, new research shows.

FRIDAY, Jan. 14, 2022 (HealthDay News) -- The severity of certain menopause symptoms is associated with worse cognitive performance among rural women, according to a study published online Jan. 10 in Menopause.